CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-14 | Bancel Stephane Chief Executive Officer | Sale | −7,120 | $211.17 | $1.5M | 5,435,789 |
| 2022-12-14 | Bancel Stephane Chief Executive Officer | Sale | −6,598 | $212.13 | $1.4M | 5,429,191 |
| 2022-12-14 | Bancel Stephane Chief Executive Officer | Sale | −5,580 | $213.06 | $1.2M | 5,423,611 |
| 2022-12-14 | Bancel Stephane Chief Executive Officer | Sale | −7,321 | $214.09 | $1.6M | 5,416,290 |
| 2022-12-14 | Bancel Stephane Chief Executive Officer | Sale | −2,928 | $215.07 | $630K | 5,413,362 |
| 2022-12-14 | Bancel Stephane Chief Executive Officer | Sale | −1,116 | $216.10 | $241K | 5,412,246 |
| 2022-12-14 | Bancel Stephane Chief Executive Officer | Sale | −300 | $216.76 | $65K | 5,411,946 |
| 2022-12-14 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 2,227,155 | ||
| 2022-12-14 | Andres Juan | Exercise or conversion | +2,000 | $20.93 | $42K | 14,803 |
| 2022-12-14 | Andres Juan | Sale | −2,000 | $195.00 | $390K | 12,803 |
| 2022-12-14 | Andres Juan | Exercise or conversion · Stock Option (Right to Buy) | −2,000 | 207,025 | ||
| 2022-12-14 | AFEYAN NOUBAR Director | Sale | −10,000 | $195.00 | $1.9M | 2,287,209 |
| 2022-12-08 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2022-12-08 | Bancel Stephane Chief Executive Officer | Sale | −12,262 | $182.19 | $2.2M | 5,439,684 |
| 2022-12-08 | Bancel Stephane Chief Executive Officer | Sale | −19,078 | $183.05 | $3.5M | 5,420,606 |
| 2022-12-08 | Bancel Stephane Chief Executive Officer | Sale | −7,622 | $184.25 | $1.4M | 5,412,984 |
| 2022-12-08 | Bancel Stephane Chief Executive Officer | Sale | −1,038 | $184.88 | $192K | 5,411,946 |
| 2022-12-08 | Bancel Stephane Chief Executive Officer | Sale | −10,000 | $179.12 | $1.8M | 6,594,880 |
| 2022-12-08 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 2,267,155 | ||
| 2022-12-08 | Klinger Shannon Thyme Chief Legal Officer | Sale | −490 | $179.15 | $88K | 4,772 |
Page 65 of 66 · 1,314 trades